[Isolation and characteristics of the new antibacterial antibiotic mutabilicin (21-31)].
D000190:Actinomyces / Q000378:metabolism; D000409:Alanine / Q000032:analysis; D000596:Amino Acids / Q000032:analysis; D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000378:metabolism; D002854:Chromatography, Paper; D003553:Cystine / Q000032:analysis; D005998:Glycine / Q000032:analysis; D007259:Infrared Rays; D010455:Peptides; D013053:Spectrophotometry; D013912:Threonine / Q000032:analysis; D014443:Tyrosine / Q000032:analysis; D014466:Ultraviolet Rays; D014633:Valine / Q000032:analysis
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D010455:Peptides; D013912:Threonine; D014443:Tyrosine; D003553:Cystine; D014633:Valine; D000409:Alanine; D005998:Glycine
Vydelenie i kharakteristika novogo antibakterial'nogo antibiotika mutabilitsina (21-31)